[2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.] / Odissea per la evidence-based medicine. Caduta e rinascita nell'anno del coronavirus.
Recenti Prog Med
; 112(1): 15-18, 2021 01.
Article
in Italian
| MEDLINE | ID: covidwho-1054909
ABSTRACT
It was a very dark year for EBM. One of the side effects of the Covid-19 pandemic is a severe compression of the evidences. Here are some worrying events. May 2020 the saga of hydroxychloroquine. October 2020 the nitazoxanide case. November 2020 Trump Administration Interferes on Expert Opinion. December 2020 the results of the trials on the first two vaccines were announced in press releases, leaving many scientific uncertainties. Peter Piot, head of the London School of Hygiene & Tropical Medicine noted that none of the CoViD-19 vaccines have offered much data to date. «It is frustrating that all of these announcements are delivered via press release, and not give us a chance to review the actual data. We desperately need total transparency on evidence and data¼, says Piot. Better now to relaunch the spread of EBM. In the issue, we have included the best EBM-based readings from the Club for Evidence-Based in Gastroenterology & Hepatology (ebgh.it).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Evidence-Based Medicine
/
Access to Information
/
Pandemics
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
North America
/
South America
/
Brazil
/
Europa
Language:
Italian
Journal:
Recenti Prog Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS